Bliss GVS Pharma Open Offer: Post-Offer Advertisement Published, Closure on Aug 10, 2026
Bliss GVS Pharma Limited's open offer, managed by SBI Capital Markets, concluded with the acquisition of 1,669 shares. The offer, for up to 2,77,26,848 shares (26% stake), opened on July 28, 2026, and closed on August 10, 2026. Post-offer advertisement published on September 1, 2026.
The actual number of shares acquired (1,669) is extremely small compared to the total shares offered (2,77,26,848), indicating a minimal impact on the company's shareholding structure or market dynamics.
The announcement is a routine post-offer advertisement providing details of an acquisition process. It does not contain any new financial results or significant business developments that would strongly influence sentiment.
Bliss GVS Pharma Limited has issued a post-offer advertisement in compliance with Regulation 18(12) of the SEBI (SAST) Regulations, 2011. This advertisement, dated August 31, 2026, appeared in The Financial Express (English), Jansatta (Hindi), and Navshakti (Marathi) on September 1, 2026. The open offer, managed by SBI Capital Markets Limited on behalf of the acquirer Anupam Rasayan India Limited and PAC Mates Visa Consultancy Private Limited, was for the acquisition of up to 2,77,26,848 equity shares, representing 26.00% of the expanded voting share capital.
The offer opened on Tuesday, July 28, 2026, and closed on Monday, August 10, 2026. The payment of consideration was scheduled for Monday, August 24, 2026. As per the post-offer advertisement, the acquirer ultimately acquired 1,669 equity shares in the open offer, representing 0.00% of the target company's equity share capital. This acquisition was directly credited to the acquirer's demat account, with plans to transfer these shares to the PAC in due course.
The advertisement also references previous announcements and documents related to the open offer, including the Public Announcement dated May 23, 2026, the Detailed Public Statement dated May 30, 2026, the Draft Letter of Offer dated June 8, 2026, and the Letter of Offer dated July 18, 2026. The post-offer advertisement is available on the websites of SEBI, NSE, BSE, and Bliss GVS Pharma Limited.
A plain-language summary of a public exchange filing by Bliss GVS Pharma Limited. Read the original for the full detail.